Potential FDA fallout from the mifepristone case

Federal<b> </b>Judge Matthew Kacsmaryk in Texas is expected to make a decision any day now on whether the FDA exceeded its authority in granting accelerated approval to abortion pill mifepristone more than 20 years ago.

Related Keywords

United States ,Texas ,Lina Khan ,Meganr Wilson ,Lawrence Tabak ,Katherine Ellen Foley ,Astellas Pharma ,Paulr Ky ,David Lim ,Robert Califf ,Thierry Bernard ,Matthew Kacsmaryk ,Scotusblog Eric Fraser ,Brumidi Group ,Government Accountability Office ,Pfizer ,Supreme Court ,Amgen Inc ,Senate Commerce Committee ,Federal Judge Matthew Kacsmaryk ,Ruth Reader ,Capitol Hill ,Federal Trade Commission ,House Appropriations Subcommittee ,Chair Andy Harris ,Sanford Bishop ,Rand Paul ,Public Citizen ,Families United States ,Eric Fraser ,